CAD 0.1
(-5.56%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | - CAD | 0.0% |
2022 | - CAD | 0.0% |
2021 | - CAD | 0.0% |
2020 | - CAD | 0.0% |
2019 | - CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 100.0% |
2014 | -125.64 CAD | 97.61% |
2013 | -5251.00 CAD | -23.44% |
2012 | -4254.00 CAD | 0.0% |
2011 | - CAD | 0.0% |
2010 | - CAD | 0.0% |
2009 | - CAD | 0.0% |
2008 | - CAD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | - CAD | 0.0% |
2024 Q1 | - CAD | 0.0% |
2023 Q4 | - CAD | 0.0% |
2023 FY | - CAD | 0.0% |
2023 Q1 | - CAD | 0.0% |
2023 Q2 | - CAD | 0.0% |
2023 Q3 | - CAD | 0.0% |
2022 Q2 | - CAD | 0.0% |
2022 Q1 | - CAD | 0.0% |
2022 Q4 | - CAD | 0.0% |
2022 Q3 | - CAD | 0.0% |
2022 FY | - CAD | 0.0% |
2021 Q2 | - CAD | 0.0% |
2021 Q3 | - CAD | 0.0% |
2021 Q4 | - CAD | 0.0% |
2021 FY | - CAD | 0.0% |
2021 Q1 | - CAD | 0.0% |
2020 Q2 | 20.43 Thousand CAD | -75.86% |
2020 FY | - CAD | 0.0% |
2020 Q4 | - CAD | 0.0% |
2020 Q1 | 84.65 Thousand CAD | 0.0% |
2020 Q3 | - CAD | -100.0% |
2019 Q2 | 1.44 Million CAD | 0.0% |
2019 FY | - CAD | 0.0% |
2019 Q4 | - CAD | -100.0% |
2019 Q3 | 480.48 Thousand CAD | -66.67% |
2019 Q1 | - CAD | 0.0% |
2018 FY | - CAD | 0.0% |
2018 Q4 | - CAD | -100.0% |
2018 Q2 | - CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2018 Q3 | 8914.97 CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2016 Q3 | - CAD | 0.0% |
2016 Q2 | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2016 Q4 | - CAD | 0.0% |
2016 Q1 | - CAD | 0.0% |
2015 Q1 | -933.67 CAD | -643.13% |
2015 FY | - CAD | 100.0% |
2015 Q4 | - CAD | 0.0% |
2015 Q3 | - CAD | 100.0% |
2015 Q2 | -1359.96 CAD | -45.66% |
2014 FY | -125.64 CAD | 97.61% |
2014 Q4 | -125.64 CAD | 97.91% |
2014 Q3 | -6000.00 CAD | -4.75% |
2014 Q2 | -5728.00 CAD | -4.18% |
2014 Q1 | -5498.00 CAD | -4.7% |
2013 Q3 | -5010.00 CAD | -5.32% |
2013 Q1 | -4266.00 CAD | -0.28% |
2013 Q2 | -4757.00 CAD | -11.51% |
2013 FY | -5251.00 CAD | -23.44% |
2013 Q4 | -5251.00 CAD | -4.81% |
2012 Q2 | - CAD | 0.0% |
2012 FY | -4254.00 CAD | 0.0% |
2012 Q4 | -4254.00 CAD | -109341.73% |
2012 Q3 | -3.89 CAD | 0.0% |
2012 Q1 | - CAD | 0.0% |
2011 Q4 | - CAD | 0.0% |
2011 Q3 | - CAD | 0.0% |
2011 Q2 | - CAD | 0.0% |
2011 Q1 | - CAD | 0.0% |
2011 FY | - CAD | 0.0% |
2010 FY | - CAD | 0.0% |
2010 Q2 | - CAD | 0.0% |
2010 Q3 | - CAD | 0.0% |
2010 Q4 | - CAD | 0.0% |
2010 Q1 | - CAD | 0.0% |
2009 FY | - CAD | 0.0% |
2009 Q4 | - CAD | 0.0% |
2008 FY | - CAD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | - CAD | NaN% |
Asep Medical Holdings Inc | - CAD | NaN% |
BioVaxys Technology Corp. | - CAD | NaN% |
ChitogenX Inc. | - CAD | NaN% |
Rapid Dose Therapeutics Corp. | 132.46 Thousand CAD | 100.0% |
Defence Therapeutics Inc. | -35.44 Thousand CAD | 100.0% |
Entheon Biomedical Corp. | -6233.00 CAD | 100.0% |
Gemina Laboratories Ltd. | - CAD | NaN% |
Glow Lifetech Corp. | 120.53 Thousand CAD | 100.0% |
Lexston Life Sciences Corp. | 46.03 Thousand CAD | 100.0% |
Pharmala Biotech Holdings Inc. | 122.19 Thousand CAD | 100.0% |
Doseology Sciences Inc. | 39.7 Thousand CAD | 100.0% |
MYND Life Sciences Inc. | - CAD | NaN% |
Nova Mentis Life Science Corp. | -6970.00 CAD | 100.0% |
PharmaTher Holdings Ltd. | -8330.00 CAD | 100.0% |
PreveCeutical Medical Inc. | - CAD | NaN% |
Telescope Innovations Corp. | - CAD | NaN% |